Cardinal Health, Inc. $CAH Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 25.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 853,158 shares of the company’s stock after selling 298,616 shares during the quarter. Pacer Advisors Inc.’s holdings in Cardinal Health were worth $133,912,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Geode Capital Management LLC raised its position in Cardinal Health by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after buying an additional 205,539 shares during the last quarter. Norges Bank acquired a new stake in shares of Cardinal Health in the second quarter worth $584,420,000. Invesco Ltd. raised its holdings in shares of Cardinal Health by 7.3% during the second quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock worth $510,347,000 after purchasing an additional 207,750 shares during the last quarter. Legal & General Group Plc lifted its position in Cardinal Health by 2.0% during the second quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after purchasing an additional 45,812 shares during the period. Finally, Marshall Wace LLP lifted its position in Cardinal Health by 19.1% during the second quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after purchasing an additional 309,335 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $207.54 on Friday. The stock has a market capitalization of $49.31 billion, a PE ratio of 31.30, a P/E/G ratio of 1.51 and a beta of 0.63. Cardinal Health, Inc. has a fifty-two week low of $117.53 and a fifty-two week high of $214.93. The company has a fifty day moving average of $195.25 and a two-hundred day moving average of $169.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter in the previous year, the company earned $1.88 earnings per share. The company’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Leerink Partners upped their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. Robert W. Baird set a $232.00 price objective on Cardinal Health in a research report on Friday, October 31st. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a report on Monday, November 3rd. Citigroup boosted their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research report on Tuesday, November 18th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $209.00.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.